Terbutaline in the treatment of chronic urticaria.
Eighteen patients with chronic urticaria were evaluated concerning the benefit of oral sympathomimetic therapy. No significant differences could be found between the sympathomimetic agent (terbutaline) and a placebo in the various clinical parameters evaluated. The authors conclude that the efficacy of this drug is doubtful in the treatment of chronic urticaria.
D000328:Adult; D002908:Chronic Disease; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011537:Pruritus / Q000188:drug therapy; D013726:Terbutaline / Q000009:adverse effects / Q000627:therapeutic use*; D014581:Urticaria / Q000188:drug therapy*
D010919:Placebos; D013726:Terbutaline